D
Power Law company profile
DICE Therapeutics
Biotech & Life Sciences · South San Francisco, United States · Founded 2013 · IPO 2021 Unicorn
Valuation
$2.40B
Market cap · 2026
Global footprint
Where DICE Therapeutics has talent and traffic
Web traffic by country
560
monthly visits
across markets
across markets
🇺🇸 United States107.1%
Patent intelligence
$6M patent portfolio · 20 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$6M
0.27% of market cap · 35.6× smaller than top peer Galapagos ($230M)
20 active patent families
Where DICE Therapeutics innovates
Pharmaceutical drugMolecular biologyUlcerative colitisIntegrinSmall molecule
Above peer median on Strategic · Below peer median on Legal, Market, Economic, Technology
Quality vs same-sector peers
DICE Therapeutics on the five Patsnap quality dimensions
DICE Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where DICE Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across DICE Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee DICE Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.